Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $3,012 | 2 | 91.1% |
| Food and Beverage | $294.41 | 13 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $3,000 | 1 | $0 (2020) |
| Novo Nordisk Inc | $83.69 | 1 | $0 (2023) |
| Roche Diagnostics Corporation | $82.45 | 4 | $0 (2019) |
| ACELL, INC. | $45.18 | 2 | $0 (2017) |
| AbbVie, Inc. | $42.68 | 3 | $0 (2019) |
| Amgen Inc. | $14.84 | 1 | $0 (2019) |
| Lupin Inc. | $14.08 | 1 | $0 (2018) |
| AMAG Pharmaceuticals, Inc. | $11.98 | 1 | $0 (2019) |
| Avion Pharmaceuticals | $11.49 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $83.69 | 1 | Novo Nordisk Inc ($83.69) |
| 2020 | $3,000 | 1 | Intuitive Surgical, Inc. ($3,000) |
| 2019 | $75.76 | 5 | Roche Diagnostics Corporation ($22.20) |
| 2018 | $61.18 | 4 | AbbVie, Inc. ($27.43) |
| 2017 | $85.76 | 4 | ACELL, INC. ($45.18) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $83.69 | General |
| Category: Obesity | ||||||
| 09/01/2020 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 05/21/2019 | Roche Diagnostics Corporation | RS Harmony Test Related Products (Device) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Sequencing | ||||||
| 05/08/2019 | Avion Pharmaceuticals | Prenate Mini (Drug), FaLessa | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Prenatal vitamin | ||||||
| 04/24/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug), MAKENA | Education | In-kind items and services | $11.98 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 02/07/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Endocrinology | ||||||
| 01/16/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Bone Health | ||||||
| 12/13/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Endocrinology | ||||||
| 11/13/2018 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: OBSTETRICSGYNECOLOGY | ||||||
| 05/14/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $13.53 | General |
| 03/19/2018 | Roche Diagnostics Corporation | RS Harmony Test Related Products (Device) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Sequencing | ||||||
| 12/07/2017 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $22.59 | General |
| 12/07/2017 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $22.59 | General |
| 08/28/2017 | Roche Diagnostics Corporation | RS Harmony Test Related Products (Device) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Sequencing | ||||||
| 03/14/2017 | Roche Diagnostics Corporation | MD cobas Instruments and Reagents (Device) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Molecular Diagnostics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 15 | $1,398 | $878.67 |
| 2022 | 1 | 22 | 22 | $678.04 | $640.25 |
| 2021 | 3 | 45 | 47 | $4,190 | $1,571 |
| 2020 | 3 | 48 | 67 | $7,172 | $1,809 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $1,398 | $878.67 | 62.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 22 | 22 | $678.04 | $640.25 | 94.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $896.64 | $664.68 | 74.1% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 19 | 21 | $2,864 | $506.36 | 17.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 14 | 14 | $429.20 | $399.84 | 93.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 26 | $1,866 | $808.01 | 43.3% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 17 | 27 | $4,882 | $579.11 | 11.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 14 | 14 | $423.50 | $422.18 | 99.7% |
About Dr. Robert Sledge, MD
Dr. Robert Sledge, MD is a Obstetrics & Gynecology healthcare provider based in Niceville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1508123829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sledge, MD has received a total of $3,306 in payments from pharmaceutical and medical device companies, with $83.69 received in 2023. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Education" ($3,012).
As a Medicare-enrolled provider, Sledge has provided services to 130 Medicare beneficiaries, totaling 151 services with total Medicare billing of $4,899. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Niceville, FL
- Active Since 04/12/2012
- Last Updated 08/06/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1508123829
Products in Payments
- Da Vinci Surgical System (Device) $3,000
- Wegovy (Drug) $83.69
- RS Harmony Test Related Products (Device) $62.03
- Orilissa (Drug) $29.15
- MD cobas Instruments and Reagents (Device) $20.42
- Prolia (Biological) $14.84
- SOLOSEC (Drug) $14.08
- INTRAROSA (Drug) $11.98
- Prenate Mini (Drug) $11.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.